Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MyNicNaxs, LLC was a Florida-based company that marketed and distributed weight loss and sexual enhancement products, primarily through its e-commerce platforms. In 2018, the company was permanently enjoined by a federal court following an FDA investigation which revealed that several of its products, marketed as "all-natural" dietary supplements, contained undeclared active pharmaceutical ingredients such as sildenafil and sibutramine. The legal action required the company to cease all operations related to the distribution of drugs and supplements until it could demonstrate full compliance with the Federal Food, Drug, and Cosmetic Act. Consequently, the company is no longer an active participant in the healthcare or nutraceutical market. Its business model focused on direct-to-consumer sales of misbranded products rather than legitimate pharmaceutical research and development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MyNicNaxs.